{"id":62306,"date":"2025-12-05T16:05:50","date_gmt":"2025-12-05T15:05:50","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\/"},"modified":"2025-12-05T16:05:50","modified_gmt":"2025-12-05T15:05:50","slug":"arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\/","title":{"rendered":"Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation"},"content":{"rendered":"
\n

NEW YORK–(BUSINESS WIRE)–Arthur D. Little (ADL) and Vega IT today announced the formation of Axceler8 Solutions, a 50\/50 joint venture created to design, develop, and operate a portfolio of digital and AI solutions aimed at improving efficiency and automating complex business processes. The launch of this new company is the direct outcome of a year of successful collaboration between the two firms and marks a new phase in their shared ambition to bring scalable, high-performance digital solutions to market, aiming to further augment their clients\u2019 capacity to compress time to impact in a variety of domains.\n<\/p>\n

<\/a>
<\/a>
<\/a>
<\/a><\/p>\n

\nAxceler8 Solutions\u2019 first product, Axceler8 Rx, is now live as a newly developed platform, and is a cloud-based application designed for pharmaceutical sponsors to accelerate clinical trial design, optimize country and site selection, and simulate patient enrolment. It combines ADL\u2019s proprietary clinical trial IP and domain expertise with Vega IT\u2019s software engineering capabilities and global experience in delivering innovative digital solutions in the healthcare sector. Key modules already delivered cover trial site selection, site activation, enrolment forecasting and an overall dashboard to visualize all aspects of clinical trial progress.\n<\/p>\n

\nThe underlying Axceler8 Rx platform is built on a modular, sector-agnostic architecture, enabling rapid development of future applications. This flexible foundation is designed to scale, supporting clients as they tackle evolving digital challenges. The two firms will work together to ensure a seamless global rollout of the platform, from providing consulting and commercialization expertise to systems integration and managed services.\n<\/p>\n

\nIgnacio Garcia Alves, Chairman and CEO at Arthur D. Little<\/b>, comments, “Axceler8 Solutions represents the next step in our partnership with Vega IT, one that turns powerful ideas into high-performance platforms. Together, we are bringing speed, scale, and intelligence to sectors that need it most, starting with life sciences.”\n<\/p>\n

\nSasa Popovic, CEO of Vega IT<\/b>, adds, “Axceler8 Solutions is built for scale, speed, and impact. Our goal is to turn complexity into clarity for our clients, delivering smart, sector-ready solutions through a flexible, reusable platform.”\n<\/p>\n

\nPhilippe Mauchard, Chief Bridge Officer at Arthur D. Little<\/b> concludes, “This joint venture is an important milestone in our Open Consulting strategy, strengthening our ability to equip clients for faster impact in AI and digital, through a set of complementary partnerships with leading organizations such as Vega IT.\u201d\n<\/p>\n

\nNOTES TO EDITORS<\/b>\n<\/p>\n

\nAbout Arthur D. Little<\/b>\n<\/p>\n

\nArthur D. Little has been at the forefront of innovation since 1886. We are an acknowledged thought leader in linking strategy, innovation and transformation in technology-intensive and converging industries. We navigate our clients through changing business ecosystems to uncover new growth opportunities. We enable our clients to build innovation capabilities and transform their organizations. Our consultants have strong practical industry experience combined with excellent knowledge of key trends and dynamics. ADL is present in the most important business centers around the world. We are proud to serve most of the Fortune 1000 companies, in addition to other leading firms and public sector organizations.\n<\/p>\n

\nVisit the website here: https:\/\/axceler8solutions.com\/<\/a>\n<\/p>\n

\nAbout Vega IT<\/b>\n<\/p>\n

\nVega IT is a digital product development and system integration partner<\/b> with over 900<\/b> experts, <\/b>delivering cutting-edge solutions that shape industries and drive businesses forward.\n<\/p>\n

\nVega IT’s expertise spans 15+ industries<\/b>, including finance, insurance, healthcare, and retail. With 2000+ successfully delivered projects<\/b>, the company has made an impact across Europe, the USA, and the Middle East<\/b>, helping clients achieve their digital transformation goals.\n<\/p>\n

\nWith development centers in Novi Sad, Zrenjanin, Belgrade, Nis, and Podgorica, as well as strategic offices in New York, London, and Riyadh, the company is actively expanding its global footprint, bringing world-class software solutions closer to its partners.\n<\/p>\n

\nAt the heart of Vega IT lies a vision to build a company that leads through innovation, deep domain expertise, and a relentless pursuit of excellence.<\/b> The company does not just write code \u2013 it engineers success, transforms businesses, and creates meaningful digital experiences.\n<\/p>\n

\nVisit the website here: https:\/\/www.vegaitglobal.com\/<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:
\n
Cate Bonthuys
\n
Catalyst Comms
\n
+44 7715 817589
\n
bonthuys.cate@adlittle.com<\/a><\/p>\n

For further information, please visit www.adlittle.com<\/a> and Software Development Company | Vega IT<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK–(BUSINESS WIRE)–Arthur D. Little (ADL) and Vega IT today announced the formation of Axceler8 Solutions, a 50\/50 joint venture created to design, develop, and operate a portfolio of digital and AI solutions aimed at improving efficiency and automating complex business processes. The launch of this new company is the direct outcome of a year … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62306","6":"format-standard","7":"category-industry"},"yoast_head":"\nArthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NEW YORK–(BUSINESS WIRE)–Arthur D. Little (ADL) and Vega IT today announced the formation of Axceler8 Solutions, a 50\/50 joint venture created to design, develop, and operate a portfolio of digital and AI solutions aimed at improving efficiency and automating complex business processes. The launch of this new company is the direct outcome of a year ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-05T15:05:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251205465303\/en\/2662124\/22\/Axceler8.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation\",\"datePublished\":\"2025-12-05T15:05:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\\\/\"},\"wordCount\":687,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251205465303\\\/en\\\/2662124\\\/22\\\/Axceler8.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\\\/\",\"name\":\"Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251205465303\\\/en\\\/2662124\\\/22\\\/Axceler8.jpg\",\"datePublished\":\"2025-12-05T15:05:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251205465303\\\/en\\\/2662124\\\/22\\\/Axceler8.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251205465303\\\/en\\\/2662124\\\/22\\\/Axceler8.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\/","og_locale":"en_US","og_type":"article","og_title":"Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation - Pharma Trend","og_description":"NEW YORK–(BUSINESS WIRE)–Arthur D. Little (ADL) and Vega IT today announced the formation of Axceler8 Solutions, a 50\/50 joint venture created to design, develop, and operate a portfolio of digital and AI solutions aimed at improving efficiency and automating complex business processes. The launch of this new company is the direct outcome of a year ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\/","og_site_name":"Pharma Trend","article_published_time":"2025-12-05T15:05:50+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251205465303\/en\/2662124\/22\/Axceler8.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation","datePublished":"2025-12-05T15:05:50+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\/"},"wordCount":687,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251205465303\/en\/2662124\/22\/Axceler8.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\/","url":"https:\/\/pharma-trend.com\/en\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\/","name":"Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251205465303\/en\/2662124\/22\/Axceler8.jpg","datePublished":"2025-12-05T15:05:50+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251205465303\/en\/2662124\/22\/Axceler8.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251205465303\/en\/2662124\/22\/Axceler8.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/arthur-d-little-and-vega-it-unveil-joint-venture-for-digital-innovation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62306","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62306"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62306\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62306"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62306"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62306"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}